98 related articles for article (PubMed ID: 17179187)
1. Choroidal detachment associated with latanoprost use in the fellow eye.
Horgan N; Kirwan RP; O'Brien CJ
Ann Pharmacother; 2007 Jan; 41(1):161-2. PubMed ID: 17179187
[No Abstract] [Full Text] [Related]
2. Choroidal detachment with topical latanoprost after glaucoma filtration surgery.
Sodhi PK; Sachdev MS; Gupta A; Verma LK; Ratan SK
Ann Pharmacother; 2004 Mar; 38(3):510-1. PubMed ID: 14970375
[No Abstract] [Full Text] [Related]
3. Choroidal detachment after the use of topical latanoprost.
Marques Pereira ML; Katz LJ
Am J Ophthalmol; 2001 Dec; 132(6):928-9. PubMed ID: 11730664
[TBL] [Abstract][Full Text] [Related]
4. Choroidal detachment after topical prostaglandin analogs: case report.
Pathanapitoon K; Kunavisarut P
J Med Assoc Thai; 2005 Aug; 88(8):1134-6. PubMed ID: 16404845
[TBL] [Abstract][Full Text] [Related]
5. Choroidal detachment following extracapsular cataract extraction in a patient treated with latanoprost.
Gupta R; Vernon SA
Br J Ophthalmol; 2001 Oct; 85(10):1268. PubMed ID: 11599505
[No Abstract] [Full Text] [Related]
6. [Melanoma during latanoprost therapy: three cases].
Estève E; Beau-Salinas F; Estève L; Lemacon JM; Autret-Leca E; Le Louet H; Hocine R; Wolkenstein P; Plaquet JL
Ann Dermatol Venereol; 2009 Jan; 136(1):60-1. PubMed ID: 19171236
[No Abstract] [Full Text] [Related]
7. Contact dermatitis caused by latanoprost-containing eye drops with good tolerance to bimatoprost eye drops.
Pérez-Rodríguez E; González-Pérez R; Poza P; Feliciano L; López-Correcher B; Matheu V
Contact Dermatitis; 2008 Jun; 58(6):370-1. PubMed ID: 18503690
[No Abstract] [Full Text] [Related]
8. Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: verification with normal subjects.
Takahashi M; Higashide T; Sakurai M; Sugiyama K
J Glaucoma; 2008; 17(3):169-74. PubMed ID: 18414100
[TBL] [Abstract][Full Text] [Related]
9. Unilateral choroidal detachment following the use of tamsulosin.
Lubbers SM; Japing WJ
Can J Ophthalmol; 2017 Apr; 52(2):e75-e77. PubMed ID: 28457310
[No Abstract] [Full Text] [Related]
10. Localizing polypoidal choroidal vasculopathy for laser treatment.
Bozzoni Pantaleoni F; Magliari Galante V; Da Dalt S; Pecorella I
Acta Ophthalmol Scand; 2007 Jun; 85(4):456-8. PubMed ID: 17263781
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
[TBL] [Abstract][Full Text] [Related]
12. Optos Optomap Panoramic 200MA imaging of a serous choroidal detachment responsive to furosemide.
Shah SP; Jain A; Tsui I; McCannel TA
Semin Ophthalmol; 2009; 24(1):40-2. PubMed ID: 19241292
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
[TBL] [Abstract][Full Text] [Related]
14. Systemic adverse effects associated with topically applied latanoprost.
Peak AS; Sutton BM
Ann Pharmacother; 1998 Apr; 32(4):504-5. PubMed ID: 9562149
[No Abstract] [Full Text] [Related]
15. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
Wang RF; Gagliuso DJ; Mittag TW; Podos SM
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of latanoprost when stored at room temperature.
Mochizuki H; Itakura H; Takamatsu M; Kiuchi Y
Hiroshima J Med Sci; 2008 Jun; 57(2):69-72. PubMed ID: 18717189
[TBL] [Abstract][Full Text] [Related]
17. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
18. The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WC
Curr Eye Res; 2007 Dec; 32(12):1037-43. PubMed ID: 18085467
[TBL] [Abstract][Full Text] [Related]
19. [Late postoperative choroidal detachment].
Zarnowski T; Rejdak R; Choragiewicz T
Klin Oczna; 2008; 110(4-6):196-8. PubMed ID: 18655461
[TBL] [Abstract][Full Text] [Related]
20. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
Konstas AG; Mikropoulos D; Dimopoulos AT; Moumtzis G; Nelson LA; Stewart WC
Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
